SCIENCE IN (Germany) Performance
| 8D9 Stock | EUR 0.28 0.01 3.45% |
SCIENCE IN has a performance score of 1 on a scale of 0 to 100. The firm has a beta of 0.11, which indicates not very significant fluctuations relative to the market. As returns on the market increase, SCIENCE IN's returns are expected to increase less than the market. However, during the bear market, the loss of holding SCIENCE IN is expected to be smaller as well. SCIENCE IN SPORT now has a risk of 4.37%. Please validate SCIENCE IN mean deviation, downside deviation, information ratio, as well as the relationship between the semi deviation and coefficient of variation , to decide if SCIENCE IN will be following its existing price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in SCIENCE IN SPORT are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, SCIENCE IN is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
SCIENCE |
SCIENCE IN Relative Risk vs. Return Landscape
If you would invest 28.00 in SCIENCE IN SPORT on October 19, 2024 and sell it today you would earn a total of 0.00 from holding SCIENCE IN SPORT or generate 0.0% return on investment over 90 days. SCIENCE IN SPORT is currently producing 0.094% returns and takes up 4.3673% volatility of returns over 90 trading days. Put another way, 38% of traded stocks are less volatile than SCIENCE, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
SCIENCE IN Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SCIENCE IN's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as SCIENCE IN SPORT, and traders can use it to determine the average amount a SCIENCE IN's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0215
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | 8D9 | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.37 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average SCIENCE IN is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SCIENCE IN by adding it to a well-diversified portfolio.
SCIENCE IN Fundamentals Growth
SCIENCE Stock prices reflect investors' perceptions of the future prospects and financial health of SCIENCE IN, and SCIENCE IN fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SCIENCE Stock performance.
| Return On Equity | -0.29 | |||
| Return On Asset | -0.0764 | |||
| Profit Margin | (0.19) % | |||
| Operating Margin | (0.13) % | |||
| Shares Outstanding | 172.42 M | |||
| Revenue | 65.55 M | |||
| EBITDA | (5.75 M) | |||
| Cash And Equivalents | 10.47 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 860 K | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 0.28 X | |||
| Cash Flow From Operations | 3.14 M | |||
| Earnings Per Share | (0.06) X | |||
About SCIENCE IN Performance
By analyzing SCIENCE IN's fundamental ratios, stakeholders can gain valuable insights into SCIENCE IN's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SCIENCE IN has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SCIENCE IN has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, and sports and fitness enthusiasts. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom. SCIENCE IN is traded on Frankfurt Stock Exchange in Germany.Things to note about SCIENCE IN SPORT performance evaluation
Checking the ongoing alerts about SCIENCE IN for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SCIENCE IN SPORT help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SCIENCE IN SPORT has some characteristics of a very speculative penny stock | |
| SCIENCE IN SPORT had very high historical volatility over the last 90 days | |
| The company reported the revenue of 65.55 M. Net Loss for the year was (1.73 M) with profit before overhead, payroll, taxes, and interest of 31.35 M. | |
| Over 94.0% of the company shares are owned by institutions such as pension funds |
- Analyzing SCIENCE IN's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SCIENCE IN's stock is overvalued or undervalued compared to its peers.
- Examining SCIENCE IN's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SCIENCE IN's management team can have a significant impact on its success or failure. Reviewing the track record and experience of SCIENCE IN's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SCIENCE IN's stock. These opinions can provide insight into SCIENCE IN's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for SCIENCE Stock analysis
When running SCIENCE IN's price analysis, check to measure SCIENCE IN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCIENCE IN is operating at the current time. Most of SCIENCE IN's value examination focuses on studying past and present price action to predict the probability of SCIENCE IN's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCIENCE IN's price. Additionally, you may evaluate how the addition of SCIENCE IN to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |